NCT05796570
- Conditions
- AML, Acute Myeloid Leukemia, Bone Marrow Diseases, +16 more
- Locations
-
- Boston Children's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Bone Marrow Failure Disorders
Explore clinical trials studying Bone Marrow Failure Disorders. Study availability and eligibility vary by location and protocol.
299 public trials
60 recruiting studies
Bone Marrow Failure Disorders trial results
Active, not recruiting
JAK1/2 Inhibitor Ruxolitinib for Relapsed/Refractory Immune Bone Marrow Failure
NCT05998408
- Conditions
- Anemia, Anemia, Aplastic, Bone Marrow Diseases, +6 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Active, not recruiting
Unrelated And Partially Matched Related Donor PSCT w/ T Cell Receptor (TCR) αβ Depletion for Patients With BMF
NCT03047746
- Conditions
- Acquired Aplastic Anemia, Anemia, Anemia, Hemolytic, +11 more
- Locations
-
- Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States
Active, not recruiting
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
NCT00544115
- Conditions
- Anemia, Anemia, Aplastic, Anemia, Hemolytic, +95 more
- Locations
-
Not specified
Active, not recruiting
Ruxolitinib Based GVHD Prophylaxis Regimen Before, During, and After Hematopoietic Cell Transplantation in Older Adult Patients With Acquired Aplastic Anemia
NCT06752694
- Conditions
- Anemia, Anemia, Aplastic, Aplastic Anemia, +4 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Active, not recruiting
Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
NCT03192397
- Conditions
- Acute Myeloid Leukemia in Remission, Adult Acute Lymphoblastic Leukemia in Complete Remission, Anemia, +45 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Active, not recruiting
Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia
NCT01623167
- Conditions
- Anemia, Anemia, Aplastic, Autoimmune Diseases, +10 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Active, not recruiting
Acute GVHD Suppression Using Costimulation Blockade to Expand Non-malignant Transplant
NCT03924401
- Conditions
- Anemia, Anemia, Aplastic, Anemia, Hemolytic, +19 more
- Locations
-
- Children's of Alabama Birmingham, Alabama, United States
- Nemours/Alfred I. DuPont Hospital for Children Wilmington, Delaware, United States
- Childrens Healthcare of Atlanta Atlanta, Georgia, United States
- Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
Active, not recruiting
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
NCT01199562
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +245 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
Active, not recruiting
Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy
NCT02979873
- Conditions
- Anemia, Anemia, Aplastic, Bone Marrow Diseases, +4 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States